Late onset azotemia from RAAS blockade in CKD patients with normal renal arteries and no precipitating risk factors.

Onuigbo, Macaulay A C; Onuigbo, Nnonyelum T C

Onuigbo, Macaulay A C; Onuigbo, Nnonyelum T C.

Affiliation

Onuigbo MA; Mayo Clinic College of Medicine, Rochester, Minnesota, USA. onuigbo.macaulay@mayo.edu

Ren Fail ; 30(1): 73-80, 2008.

Article in En | MEDLINE | ID: mdl-18197547

Subject(s)

Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Azotemia/chemically induced; Kidney Failure, Chronic/pathology; Renal Artery/pathology; Renin-Angiotensin System/drug effects; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Azotemia/physiopathology; Female; Glomerular Filtration Rate; Humans; Kidney/blood supply; Kidney Failure, Chronic/drug therapy; Kidney Failure, Chronic/physiopathology; Male; Microcirculation; Middle Aged; Risk Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Renal Artery / Renin-Angiotensin System / Angiotensin-Converting Enzyme Inhibitors / Azotemia / Angiotensin Receptor Antagonists / Kidney Failure, Chronic Type of study: Etiology_studies / Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ren Fail Journal subject: NEFROLOGIA Year: 2008 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google